AUSTIN, Texas, July 1, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life ...

Luminex’s xMAP Technology will be deployed by the HPA project to perform flexible and high-throughput screening of biomarkers using the HPA antibodies on large numbers of samples. The same technology ...

In order to emit less contaminants into the environment, and at the same time produce healthier foods that are free of those contaminants, all production systems should be investigated, i.e. whether ...

Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP® Technology uses color-coded microspheres as the substrate on which ...

Luminex Corporation LMNX recently delivered the first of its new xMAP INTELLIFLEX Systems to several of its Life Science Research Partners. This marks a significant milestone in the company’s strategy ...

"We are excited to have scientists from around the world share their latest research and to see the continued growth in new applications for multiplexing technology," said Paul C. Ladestein, General ...

Shares of Luminex CorporationLMNX have been shining bright lately with a strong one-year return of approximately 12.1%, better than the S&P 500's 4.9% over the same period. Meanwhile, the company ...

Quickly detecting and identifying dangerous biotoxins is now a reality, thanks to the xMAP® Biothreat Toxin Panel (BTP) by Luminex. The xMAP Biothreat Toxin Panel is the first multiplex assay to ...

One Lambda Inc., a leading manufacturer and supplier of quality products and technology for the HLA transplant community, and Luminex Corporation have agreed to a long-term renewal of their 10-year ...